XTL Biopharmaceuticals Ownership 2024 | Who Owns XTL Biopharmaceuticals Now?

OverviewFinancials Chart

Institutional Ownership

0.10%

Insider Ownership

5.30%

Retail Ownership

94.60%

Institutional Holders

1.00

XTL Biopharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
NOKED ISRAEL LTD	3.65%	0.13%	198,888	-	-	483,000	Jun 30, 2024
MORGAN STANLEY	0.61%	-	33,151	-6,020	-15.37%	80,557	Jun 30, 2024
RHUMBLINE ADVISERS	0.10%	-	5,584	5,584	100.00%	13,232	Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC	-	-	-	-300	-100.00%	-	Jun 30, 2024
UBS GROUP AG	-	-	-	-6,954	-100.00%	-	Jun 30, 2024

XTL Biopharmaceuticals's largest institutional shareholder is NOKED ISRAEL LTD, holding 3.65% of the company's total share outstanding, currently valued at $483.00K. The top 10 institutional shareholders own together 4.36% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
NOKED ISRAEL LTD	3.65%	0.13%	198,888	-	-	483,000	Jun 30, 2024
RHUMBLINE ADVISERS	0.10%	-	5,584	5,584	100.00%	13,232	Jun 30, 2024
MORGAN STANLEY	0.61%	-	33,151	-6,020	-15.37%	80,557	Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC	-	-	-	-300	-100.00%	-	Jun 30, 2024
UBS GROUP AG	-	-	-	-6,954	-100.00%	-	Jun 30, 2024

The largest XTL Biopharmaceuticals shareholder by % of total assets is NOKED ISRAEL LTD. The company owns 198.89K shares of XTL Biopharmaceuticals (XTLB), representing 0.13% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RHUMBLINE ADVISERS	0.10%	-	5,584	5,584	100.00%	13,232	Jun 30, 2024
NOKED ISRAEL LTD	3.65%	0.13%	198,888	-	-	483,000	Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC	-	-	-	-300	-100.00%	-	Jun 30, 2024
MORGAN STANLEY	0.61%	-	33,151	-6,020	-15.37%	80,557	Jun 30, 2024
UBS GROUP AG	-	-	-	-6,954	-100.00%	-	Jun 30, 2024

As of Jun 30 2024, XTL Biopharmaceuticals's largest institutional buyer is RHUMBLINE ADVISERS. The company purchased 5.58K stocks of XTLB, valued at $13.23K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
UBS GROUP AG	-	-	-	-6,954	-100.00%	-	Jun 30, 2024
MORGAN STANLEY	0.61%	-	33,151	-6,020	-15.37%	80,557	Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC	-	-	-	-300	-100.00%	-	Jun 30, 2024
NOKED ISRAEL LTD	3.65%	0.13%	198,888	-	-	483,000	Jun 30, 2024
RHUMBLINE ADVISERS	0.10%	-	5,584	5,584	100.00%	13,232	Jun 30, 2024

As of Jun 30 2024, XTL Biopharmaceuticals's biggest institutional seller is UBS GROUP AG. The company sold -6.95K shares of XTLB, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RHUMBLINE ADVISERS	0.10%	-	5,584	5,584	100.00%	13,232	Jun 30, 2024

XTL Biopharmaceuticals's largest new institutional shareholder by number of shares is RHUMBLINE ADVISERS, purchased 5.58K shares, valued at $13.23K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
UBS GROUP AG	-	-	-	-6,954	-100.00%	-	Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC	-	-	-	-300	-100.00%	-	Jun 30, 2024

XTL Biopharmaceuticals's largest sold out institutional shareholder by shares sold is UBS GROUP AG, sold -6.95K shares, valued at -, as of undefined.

XTL Biopharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY CONCORD STREET TRUST	0.00%	8,903	-	-	Feb 29, 2024
TRUST FOR PROFESSIONAL MANAGERS	0.00%	5,461	-	-	Feb 29, 2024

XTL Biopharmaceuticals's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 8.90K shares, compromising 0.00% of its total assets.

XTL Biopharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	1	-80.00%
31 Mar, 24	5	-
31 Dec, 23	5	25.00%
30 Sep, 23	4	33.33%
30 Jun, 23	3	50.00%
31 Mar, 23	2	-33.33%
31 Dec, 22	3	-
30 Sep, 22	3	-
30 Jun, 22	3	-25.00%
31 Mar, 22	4	-
31 Dec, 21	4	-33.33%
30 Sep, 21	6	20.00%
30 Jun, 21	5	-16.67%
31 Mar, 21	6	50.00%
31 Dec, 20	4	-
30 Sep, 20	4	33.33%
30 Jun, 20	3	-
31 Mar, 20	3	-25.00%
31 Dec, 19	4	-33.33%
30 Sep, 19	6	20.00%
30 Jun, 19	5	-
31 Mar, 19	5	-16.67%
31 Dec, 18	6	50.00%
30 Sep, 18	4	-20.00%
30 Jun, 18	5	25.00%
31 Mar, 18	4	33.33%
31 Dec, 17	3	-25.00%
30 Sep, 17	4	33.33%
30 Jun, 17	3	-
31 Mar, 17	3	-

As of 30 Jun 24, 1 institutions are holding XTL Biopharmaceuticals's shares, representing a decrease of -80.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	5,584	-97.84%
31 Mar, 24	258,944	8.25%
31 Dec, 23	239,213	-0.28%
30 Sep, 23	239,879	-0.16%
30 Jun, 23	240,259	-0.17%
31 Mar, 23	240,659	-0.62%
31 Dec, 22	242,159	-45.34%
30 Sep, 22	443,047	-0.78%
30 Jun, 22	446,547	-0.29%
31 Mar, 22	447,859	-5.14%
31 Dec, 21	472,127	-3.14%
30 Sep, 21	487,426	-2.65%
30 Jun, 21	500,698	-1.53%
31 Mar, 21	508,501	7.25%
31 Dec, 20	474,130	6.25%
30 Sep, 20	446,243	1.51%
30 Jun, 20	439,607	0.43%
31 Mar, 20	437,707	0.43%
31 Dec, 19	435,831	-9.48%
30 Sep, 19	481,451	3.92%
30 Jun, 19	463,299	-0.32%
31 Mar, 19	464,799	-0.01%
31 Dec, 18	464,842	375.60%
30 Sep, 18	97,739	-6.74%
30 Jun, 18	104,805	138.46%
31 Mar, 18	43,951	17.44%
31 Dec, 17	37,425	-24.72%
30 Sep, 17	49,712	1.60%
30 Jun, 17	48,930	32.81%
31 Mar, 17	36,841	-

XTL Biopharmaceuticals (XTLB) has 5.58K shares outstanding as of 30 Jun 24, down -97.84% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	0.10%	0.45%
31 Mar, 24	4.75%	246579.27%
31 Dec, 23	0.04%	0.23%
30 Sep, 23	4.40%	22.64%
30 Jun, 23	4.41%	22.60%
31 Mar, 23	4.42%	22.36%
31 Dec, 22	4.44%	6.72%
30 Sep, 22	8.13%	12.11%
30 Jun, 22	8.19%	12.13%
31 Mar, 22	8.22%	10.08%
31 Dec, 21	9.03%	10.39%
30 Sep, 21	9.32%	10.16%
30 Jun, 21	9.58%	9.79%
31 Mar, 21	9.89%	11.63%
31 Dec, 20	9.22%	12.24%
30 Sep, 20	8.68%	11.87%
30 Jun, 20	8.55%	11.80%
31 Mar, 20	8.51%	3.67%
31 Dec, 19	15.24%	5.38%
30 Sep, 19	16.83%	6.42%
30 Jun, 19	16.20%	6.13%
31 Mar, 19	16.25%	6.15%
31 Dec, 18	16.25%	139.17%
30 Sep, 18	3.42%	25.45%
30 Jun, 18	3.66%	155.18%
31 Mar, 18	1.54%	89.74%
31 Dec, 17	1.31%	43.31%
30 Sep, 17	1.74%	59.39%
30 Jun, 17	1.71%	103.11%
31 Mar, 17	1.29%	-

As of 30 Jun 24, XTL Biopharmaceuticals is held by 0.10% institutional shareholders, representing a 0.45% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	1	-50.00%
31 Mar, 24	2	100.00%
31 Dec, 23	1	-50.00%
30 Sep, 23	2	100.00%
30 Jun, 23	1	-
31 Mar, 23	-	-100.00%
31 Dec, 22	1	-
30 Sep, 22	-	-
30 Jun, 22	-	-100.00%
31 Mar, 22	1	-
31 Dec, 21	1	-50.00%
30 Sep, 21	2	100.00%
30 Jun, 21	1	-66.67%
31 Mar, 21	3	50.00%
31 Dec, 20	2	-
30 Sep, 20	2	100.00%
30 Jun, 20	1	-
31 Mar, 20	1	-
31 Dec, 19	1	-50.00%
30 Sep, 19	2	100.00%
30 Jun, 19	1	-
31 Mar, 19	1	-80.00%
31 Dec, 18	5	66.67%
30 Sep, 18	3	-
30 Jun, 18	3	-
31 Mar, 18	3	200.00%
31 Dec, 17	1	-50.00%
30 Sep, 17	2	-
30 Jun, 17	2	-33.33%
31 Mar, 17	3	-

1 institutional shareholders have increased their position in XTLB stock as of 30 Jun 24 compared to 2 in the previous quarter (a -50.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	-	-100.00%
31 Mar, 24	1	-50.00%
31 Dec, 23	2	100.00%
30 Sep, 23	1	-
30 Jun, 23	1	-
31 Mar, 23	1	-
31 Dec, 22	1	-
30 Sep, 22	1	-
30 Jun, 22	1	-
31 Mar, 22	1	-
31 Dec, 21	1	-50.00%
30 Sep, 21	2	-
30 Jun, 21	2	100.00%
31 Mar, 21	1	-
31 Dec, 20	-	-
30 Sep, 20	-	-
30 Jun, 20	-	-
31 Mar, 20	-	-100.00%
31 Dec, 19	1	-66.67%
30 Sep, 19	3	200.00%
30 Jun, 19	1	-
31 Mar, 19	1	-
31 Dec, 18	-	-
30 Sep, 18	-	-100.00%
30 Jun, 18	1	-
31 Mar, 18	-	-100.00%
31 Dec, 17	1	-
30 Sep, 17	1	-
30 Jun, 17	-	-
31 Mar, 17	-	-

- institutional shareholders have reduced their position in XTLB stock as of 30 Jun 24 compared to 1 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	1	-80.00%	5,584	-97.84%	0.10%	0.45%	1	-50.00%	-	-100.00%
31 Mar, 24	5	-	258,944	8.25%	4.75%	246579.27%	2	100.00%	1	-50.00%
31 Dec, 23	5	25.00%	239,213	-0.28%	0.04%	0.23%	1	-50.00%	2	100.00%
30 Sep, 23	4	33.33%	239,879	-0.16%	4.40%	22.64%	2	100.00%	1	-
30 Jun, 23	3	50.00%	240,259	-0.17%	4.41%	22.60%	1	-	1	-
31 Mar, 23	2	-33.33%	240,659	-0.62%	4.42%	22.36%	-	-100.00%	1	-
31 Dec, 22	3	-	242,159	-45.34%	4.44%	6.72%	1	-	1	-
30 Sep, 22	3	-	443,047	-0.78%	8.13%	12.11%	-	-	1	-
30 Jun, 22	3	-25.00%	446,547	-0.29%	8.19%	12.13%	-	-100.00%	1	-
31 Mar, 22	4	-	447,859	-5.14%	8.22%	10.08%	1	-	1	-
31 Dec, 21	4	-33.33%	472,127	-3.14%	9.03%	10.39%	1	-50.00%	1	-50.00%
30 Sep, 21	6	20.00%	487,426	-2.65%	9.32%	10.16%	2	100.00%	2	-
30 Jun, 21	5	-16.67%	500,698	-1.53%	9.58%	9.79%	1	-66.67%	2	100.00%
31 Mar, 21	6	50.00%	508,501	7.25%	9.89%	11.63%	3	50.00%	1	-
31 Dec, 20	4	-	474,130	6.25%	9.22%	12.24%	2	-	-	-
30 Sep, 20	4	33.33%	446,243	1.51%	8.68%	11.87%	2	100.00%	-	-
30 Jun, 20	3	-	439,607	0.43%	8.55%	11.80%	1	-	-	-
31 Mar, 20	3	-25.00%	437,707	0.43%	8.51%	3.67%	1	-	-	-100.00%
31 Dec, 19	4	-33.33%	435,831	-9.48%	15.24%	5.38%	1	-50.00%	1	-66.67%
30 Sep, 19	6	20.00%	481,451	3.92%	16.83%	6.42%	2	100.00%	3	200.00%
30 Jun, 19	5	-	463,299	-0.32%	16.20%	6.13%	1	-	1	-
31 Mar, 19	5	-16.67%	464,799	-0.01%	16.25%	6.15%	1	-80.00%	1	-
31 Dec, 18	6	50.00%	464,842	375.60%	16.25%	139.17%	5	66.67%	-	-
30 Sep, 18	4	-20.00%	97,739	-6.74%	3.42%	25.45%	3	-	-	-100.00%
30 Jun, 18	5	25.00%	104,805	138.46%	3.66%	155.18%	3	-	1	-
31 Mar, 18	4	33.33%	43,951	17.44%	1.54%	89.74%	3	200.00%	-	-100.00%
31 Dec, 17	3	-25.00%	37,425	-24.72%	1.31%	43.31%	1	-50.00%	1	-
30 Sep, 17	4	33.33%	49,712	1.60%	1.74%	59.39%	2	-	1	-
30 Jun, 17	3	-	48,930	32.81%	1.71%	103.11%	2	-33.33%	-	-
31 Mar, 17	3	-	36,841	-	1.29%	-	3	-	-	-

XTL Biopharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	24,681,360	$0.14	$3.48M	32,876,710
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	2,696,450	$0.15	$412.02K	30,180,260
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	9,600,000	$0.15	$1.47M	20,580,260
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	29,740	$0.16	$4.73K	3,042,820
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	400,000	$0.16	$64.56K	2,642,820
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	1,943,250	$0.14	$273.80K	699,570
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	400,000	$0.15	$61.12K	299,570
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	299,570	$0.15	$45.77K	-

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	24,681,360	$0.14	$3.48M	32,876,710
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	2,696,450	$0.15	$412.02K	30,180,260
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	9,600,000	$0.15	$1.47M	20,580,260
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	29,740	$0.16	$4.73K	3,042,820
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	400,000	$0.16	$64.56K	2,642,820
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	1,943,250	$0.14	$273.80K	699,570
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	400,000	$0.15	$61.12K	299,570
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	299,570	$0.15	$45.77K	-
Nov 04, 2008	WEISS MICHAEL S	director	-	G-Gift	Sell	3,083,333	$0.36	$1.11M	9,666,667
Nov 04, 2008	ZUERBLIS KENNETH J	director	-		Sell	300,000	$0.20	$59.40K	-
Nov 04, 2008	Rudman Samuel	director	-		Sell	300,000	$0.20	$59.40K	-
Nov 04, 2008	KENNEDY WILLIAM JAMES	director	-		Sell	300,000	$0.35	$105.00K	-
Nov 04, 2008	KENNEDY WILLIAM JAMES	director	-		Sell	60,000	$0.85	$51.18K	-
Nov 04, 2008	KENNEDY WILLIAM JAMES	director	-		Sell	20,000	$0.33	$6.50K	-
Nov 04, 2008	KENNEDY WILLIAM JAMES	director	-		Sell	20,000	$0.20	$4.08K	-
Nov 04, 2008	KENNEDY WILLIAM JAMES	director	-		Sell	20,000	$0.37	$7.36K	-
Nov 04, 2008	GOOD JENNIFER L	director	-		Sell	300,000	$0.20	$59.40K	-
Sep 04, 2008	WEINER BEN-ZION	director	-		Sell	-	-	-	2,000,000

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	24,681,360	$0.14	$3.48M	32,876,710
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	2,696,450	$0.15	$412.02K	30,180,260
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	9,600,000	$0.15	$1.47M	20,580,260
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	29,740	$0.16	$4.73K	3,042,820
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	400,000	$0.16	$64.56K	2,642,820
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	1,943,250	$0.14	$273.80K	699,570
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	400,000	$0.15	$61.12K	299,570
Dec 03, 2008	EDELMAN JOSEPH	10 percent owner	-	S-Sale	Sell	299,570	$0.15	$45.77K	-
Nov 04, 2008	WEINER BEN-ZION	director	-	A-Award	Buy	300,000	$0.20	$59.40K	2,300,000
Nov 04, 2008	WEISS MICHAEL S	director	-	G-Gift	Sell	3,083,333	$0.36	$1.11M	9,666,667
Nov 04, 2008	WEISS MICHAEL S	director	-	A-Award	Buy	3,500,000	$0.20	$693.00K	3,500,000
Nov 04, 2008	ZUERBLIS KENNETH J	director	-		Sell	300,000	$0.20	$59.40K	-
Nov 04, 2008	Rudman Samuel	director	-		Sell	300,000	$0.20	$59.40K	-
Nov 04, 2008	KENNEDY WILLIAM JAMES	director	-		Sell	300,000	$0.35	$105.00K	-
Nov 04, 2008	KENNEDY WILLIAM JAMES	director	-		Sell	60,000	$0.85	$51.18K	-
Nov 04, 2008	KENNEDY WILLIAM JAMES	director	-		Sell	20,000	$0.33	$6.50K	-
Nov 04, 2008	KENNEDY WILLIAM JAMES	director	-		Sell	20,000	$0.20	$4.08K	-
Nov 04, 2008	KENNEDY WILLIAM JAMES	director	-		Sell	20,000	$0.37	$7.36K	-
Nov 04, 2008	GOOD JENNIFER L	director	-		Sell	300,000	$0.20	$59.40K	-
Sep 04, 2008	WEINER BEN-ZION	director	-		Sell	-	-	-	2,000,000

The last insider sell of XTL Biopharmaceuticals's stock was made by EDELMAN JOSEPH on Dec 03 2008, selling 24,681,360 shares at $0.14 per share (valued at $3.48M).

XTL Biopharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2008	2	11	18.18%
Q3 2008	-	4	-
Q2 2008	28	-	-
Q1 2008	143	-	-
Q4 2007	6	1	600.00%
Q3 2007	1	1	100.00%
Q1 2007	2	-	-
Q3 2006	1	1	100.00%
Q3 2005	-	5	-
Q1 2005	1	-	-

2 total buy trades, and 11 total sell trades (buy/sell ratio of 0.18%) were made by XTL Biopharmaceuticals's insiders, as of Q4 2008.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2008	-	8	-
Q3 2008	-	-	-
Q2 2008	28	-	-
Q1 2008	143	-	-
Q4 2007	6	-	-
Q3 2007	1	-	-
Q1 2007	2	-	-
Q3 2006	1	-	-
Q3 2005	-	-	-
Q1 2005	1	-	-

As of Q4 2008, Insider owners conducted 0 open market buy trades and 8 open market sell trades of XTL Biopharmaceuticals's stocks.

XTL Biopharmaceuticals Peer Ownership

Ticker	Company
PRPH	ProPhase Labs, Inc.
XBIO	Xenetic Biosciences, Inc.
BOSC	B.O.S. Better Online Solutions Ltd.
BVXV	Scinai Immunotherapeutics Ltd.
BNTC	Benitec Biopharma Inc.

XTLB Ownership FAQ

Who Owns XTL Biopharmaceuticals?

XTL Biopharmaceuticals is owned by institutional shareholders (0.10%), insiders (5.30%), and public (94.60%). The largest institutional shareholder of XTL Biopharmaceuticals is NOKED ISRAEL LTD (3.65% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).

Who are the major institutional shareholders of XTL Biopharmaceuticals?

XTL Biopharmaceuticals's major institutional shareholders are NOKED ISRAEL LTD, MORGAN STANLEY, RHUMBLINE ADVISERS, BNP PARIBAS ARBITRAGE, SNC, and UBS GROUP AG. The top five shareholders own together 4.36% of the company's share outstanding.

How many XTL Biopharmaceuticals shareholders are there?

As of Jun 2024, there are 1 institutional shareholders of XTL Biopharmaceuticals.

What percentage of XTL Biopharmaceuticals is owned by NOKED ISRAEL LTD?

NOKED ISRAEL LTD owns 198.89K shares of XTL Biopharmaceuticals, representing 3.65% of the company's total shares outstanding, valued at $483K (as of Jun 2024).

What percentage of XTL Biopharmaceuticals is owned by MORGAN STANLEY?

As of Jun 2024, MORGAN STANLEY holds 33.15K shares of XTL Biopharmaceuticals (XTLB), compromising 0.61% of the company, valued at $80.56K.

What percentage of XTL Biopharmaceuticals is owned by RHUMBLINE ADVISERS?

RHUMBLINE ADVISERS is the third largest holder of XTL Biopharmaceuticals. The company owns 5.58K of the company's shares outstanding (worth $13.23K).